The overexpression of ZEB1 has been observed in prostate cancer, gastric cancer, osteosarcoma and hepatocellular carcinoma, suggesting an important role in tumorigenesis (11,20–22). This evidence concerns the gene ZEB1 and prostate carcinoma.